International Stem Cell Corporation
ISCO · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,041 | $1,281 | $961 | $651 |
| - Cash | $966 | $920 | $1,452 | $1,230 |
| + Debt | $486 | $3,845 | $4,095 | $3,840 |
| Enterprise Value | $561 | $4,206 | $3,604 | $3,261 |
| Revenue | $2,369 | $2,447 | $2,129 | $2,446 |
| % Growth | -3.2% | 14.9% | -13% | – |
| Gross Profit | $1,321 | $1,520 | $1,137 | $1,456 |
| % Margin | 55.8% | 62.1% | 53.4% | 59.5% |
| EBITDA | $114 | $221 | -$160 | $104 |
| % Margin | 4.8% | 9% | -7.5% | 4.3% |
| Net Income | $57 | $129 | -$256 | $11 |
| % Margin | 2.4% | 5.3% | -12% | 0.4% |
| EPS Diluted | 0.007 | 0.008 | -0.032 | 0.001 |
| % Growth | -16.7% | 126.3% | -2,385.7% | – |
| Operating Cash Flow | $49 | -$300 | $227 | -$74 |
| Capital Expenditures | -$3 | -$32 | -$5 | -$3 |
| Free Cash Flow | $46 | -$332 | $222 | -$77 |